The european commission in Covid-19 vaccine cooperation: leadership vs coronationalism?

被引:10
|
作者
Deters, Henning [1 ]
Zardo, Federica [2 ]
机构
[1] Univ Vienna, EIF Ctr European Integrat Res, Dept Polit Sci, Vienna, Austria
[2] Danube Univ Krems, Dept Migrat & Globalisat, Krems, Austria
关键词
COVAX; COVID-19; European Commission; leadership; procurement; vaccines; EU;
D O I
10.1080/13501763.2022.2064900
中图分类号
D0 [政治学、政治理论];
学科分类号
0302 ; 030201 ;
摘要
During the first weeks of the Covid-19 pandemic, European Union (EU) member states competed over scarce countermeasures. Regarding vaccines, a few member states launched exclusive joint endeavours, yet eventually, the EU centralised vaccine provisioning. The EU's external vaccine diplomacy proceeded almost inversely. After stepping into the breach in global health governance, European leadership faltered and global collaboration progressed more slowly. This article explores Europe's diverging trajectories in the regional and global provisioning of Covid-19 vaccines. Focussing on the European Commission's leadership, we investigate to what extent it promoted regional and international cooperation and with what success. We also explain which factors enabled and constrained Commission leadership. Employing a controlled comparison and process tracing, we find that Commission leadership was more extensive and impactful in regional than in global vaccine provisioning. Member state support was the main enabling condition. Without support, institutional capacity and resources were insufficient for impactful leadership.
引用
收藏
页码:1051 / 1071
页数:21
相关论文
共 50 条
  • [31] Shades of COVID-19 vaccine
    Sankey, Sana Mariam
    Ailenei, Elena
    Paul, Manju
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (06) : E251 - E252
  • [32] Race for covid-19 vaccine
    Pious, Neetha
    Ingole, Sumedh Deorao
    [J]. Trends in Biomaterials and Artificial Organs, 2020, 34 : 62 - 65
  • [33] COVID-19 Vaccine Effectiveness
    Shader, Richard I.
    [J]. CLINICAL THERAPEUTICS, 2021, 43 (06) : 1132 - 1133
  • [34] COVID-19 vaccine and anaphylaxis
    Joob, B.
    Wiwanitkit, V.
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2021, 205 (06): : 631 - 631
  • [35] Vaccine and COVID-19 Trajectories
    Choi, Kate H.
    Denice, Patrick A.
    Ramaj, Sagi
    [J]. SOCIUS, 2021, 7
  • [36] COVID-19 vaccine safety
    Amaro Hosey, Kristopher
    Quijada Manuitt, Maria Angeles
    Antoniajoan Arbos, Rosa
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 32 - 32
  • [37] COVID-19: The race for a vaccine
    Lockey, Emily
    [J]. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2020, 21 (02)
  • [38] The Russian vaccine for COVID-19
    Burki, Talha Khan
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (11): : E85 - E86
  • [39] The COVID-19 Vaccine Landscape
    Koch, Till
    Fathi, Anahita
    Addo, Marylyn M.
    [J]. CORONAVIRUS DISEASE - COVID-19, 2021, 1318 : 549 - 573
  • [40] Race for a COVID-19 vaccine
    不详
    [J]. EBIOMEDICINE, 2020, 55